Literature DB >> 7263392

Respiratory drives and exercise in menstrual cycles of athletic and nonathletic women.

R B Schoene, H T Robertson, D J Pierson, A P Peterson.   

Abstract

To investigate the influence of the midluteal and midfollicular phases of the menstrual cycle on exercise performance and ventilatory drives, we studied six outstanding female athletes, six controls with normal menstrual cycles, and six outstanding athletes who were amenorrheic. In all menstruating subjects resting minute ventilation (Ve) and mouth occlusion pressures (P0.1) were higher in the luteal phase (p less than k0.0001 and p less than 0.02, respectively),. Hypoxic (expressed as the hyperbolic shape parameter A) and hypercapnic (expressed as S, deltaVE/delta PAco2) ventilatory responses were increase in the luteal phase (p less than 0.01). The athletes had lower A values during the luteal phase than the nonathletes (p less than 0.001). Maximal exercise response, expressed either as total exercise time or maximum O2 consumption or CO2 production (VO2 max or Vco2 max) was decreased during the luteal phase but was significantly different at a p less than 0.05 level only among the nonathletes. Ventilatory equivalent (VE/VO2) during progressive exercise on a bicycle ergometer was significantly increased during the luteal phase. The amenorrheic athletes showed no changes between the two test periods. The luteal phase of the menstrual cycle induced increases in ventilatory drives and exercise ventilation in both athletes and controls, but the athletes, in contrast to controls, demonstrated no significant decrease in exercise performance in the luteal phase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263392     DOI: 10.1152/jappl.1981.50.6.1300

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  39 in total

Review 1.  The physiology of the highly trained female endurance runner.

Authors:  M Burrows; S Bird
Journal:  Sports Med       Date:  2000-10       Impact factor: 11.136

2.  Do gender differences exist in the ventilatory response to progressive exercise in males and females of average fitness?

Authors:  Emma Kilbride; Paul McLoughlin; Charles G Gallagher; Helen R Harty
Journal:  Eur J Appl Physiol       Date:  2003-05-17       Impact factor: 3.078

Review 3.  Effects of the menstrual cycle on exercise performance.

Authors:  Xanne A K Janse de Jonge
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

4.  Impact of menstrual cycle phase on the exercise status of young, sedentary women.

Authors:  Leanne M Redman; Garry C Scroop; Robert J Norman
Journal:  Eur J Appl Physiol       Date:  2003-07-26       Impact factor: 3.078

Review 5.  Physiological responses to the menstrual cycle: implications for the development of heat illness in female athletes.

Authors:  Susan A Marsh; David G Jenkins
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

6.  Cycling time trial performance during different phases of the menstrual cycle.

Authors:  Tanja Oosthuyse; Andrew N Bosch; Susan Jackson
Journal:  Eur J Appl Physiol       Date:  2005-03-19       Impact factor: 3.078

Review 7.  Sports injuries and oral contraceptive use. Is there a relationship?

Authors:  J Möller Nielsen; M Hammar
Journal:  Sports Med       Date:  1991-09       Impact factor: 11.136

8.  Effects of losartan and allopurinol on cardiorespiratory regulation in obstructive sleep apnoea.

Authors:  Barbara J Morgan; Mihaela Teodorescu; David F Pegelow; Emily R Jackson; Devin L Schneider; David T Plante; James P Gapinski; Scott J Hetzel; John M Dopp
Journal:  Exp Physiol       Date:  2018-06-08       Impact factor: 2.969

9.  Ageing and cardiorespiratory response to hypoxia.

Authors:  François J Lhuissier; Florence Canouï-Poitrine; Jean-Paul Richalet
Journal:  J Physiol       Date:  2012-08-20       Impact factor: 5.182

10.  Sex differences in respiratory exercise physiology.

Authors:  A William Sheel; Jennifer C Richards; Glen E Foster; Jordan A Guenette
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.